AAAAAA

   
Results: 1-12 |
Results: 12
A CLOSED MEDICAL INTENSIVE-CARE UNIT (MICU) IMPROVES RESOURCE UTILIZATION WHEN COMPARED WITH AN OPEN MICU
Authors: MULTZ AS CHALFIN DB SAMSON IM DANTZKER DR FEIN AM STEINBERG HN NIEDERMAN MS SCHARF SM
Citation: As. Multz et al., A CLOSED MEDICAL INTENSIVE-CARE UNIT (MICU) IMPROVES RESOURCE UTILIZATION WHEN COMPARED WITH AN OPEN MICU, American journal of respiratory and critical care medicine, 157(5), 1998, pp. 1468-1473
EVIDENCE-BASED MEDICINE AND COST-EFFECTIVENESS ANALYSIS
Authors: CHALFIN DB
Citation: Db. Chalfin, EVIDENCE-BASED MEDICINE AND COST-EFFECTIVENESS ANALYSIS, Critical care clinics, 14(3), 1998, pp. 525
PULMONARY-ARTERY-CATHETER-CONSENSUS-CONFERENCE - CONSENSUS STATEMENT
Authors: TAYLOR RW AHRENS T VIEJO A BEILIN Y BENNETT ED BERNARD GR CALVIN JE CHALFIN DB CIVETTA JM CONNORS AF DAVIS R FULKERSON WJ FUHRMAN BP HERNAN LJ HOLLENBERG SM HOYT JW KELSO LA KIRTON OC LEIBOWITZ AB MATUSCHAK GM NELSON LD PAPADAKOS PJ PARKER MM PERUZZI WT SANDHAM JD SPRUNG CL THOMPSON AE TROTTIER SJ VENDER JS BEKES CE DELLINGER RP PARRILLO JE
Citation: Rw. Taylor et al., PULMONARY-ARTERY-CATHETER-CONSENSUS-CONFERENCE - CONSENSUS STATEMENT, Critical care medicine, 25(6), 1997, pp. 910-925
CLINICAL AND ECONOMIC OUTCOME OF PATIENTS UNDERGOING TRACHEOSTOMY FORPROLONGED MECHANICAL VENTILATION IN NEW-YORK-STATE DURING 1993 - ANALYSIS OF 6,353 CASES UNDER DIAGNOSIS-RELATED GROUP-483
Authors: KUREK CJ COHEN IL LAMBRINOS J MINATOYA K BOOTH FVM CHALFIN DB
Citation: Cj. Kurek et al., CLINICAL AND ECONOMIC OUTCOME OF PATIENTS UNDERGOING TRACHEOSTOMY FORPROLONGED MECHANICAL VENTILATION IN NEW-YORK-STATE DURING 1993 - ANALYSIS OF 6,353 CASES UNDER DIAGNOSIS-RELATED GROUP-483, Critical care medicine, 25(6), 1997, pp. 983-988
USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS
Authors: KNAUS WA HARRELL FE LABRECQUE JF WAGNER DP PRIBBLE JP DRAPER EA FISHER CJ SOLL L ASTIZ M RACKOW EC CARPATI C BALK RA FRIEDMAN B MURE AJ SHAPIRO E MELHOM L SHAPIRO MJ TAYLOR R KEEGAN M OBRIEN J GREENMAN RL SCHEIN R PENA M WASSERLOUF M IBERTI TJ OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAN N MERRICK DK BERQUIST W MATZEL K HUEBLER M FOULKE G ALBERTSON T WALBY W ALLEN R BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMAS BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C GERVICH D BRASE R BAGDAHN A COONEY R SMITH JS VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN H DURKIN M STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUVEN PAM BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL J KRUGER R DRUMMOND A FISHER CS LANGE P SELFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY S COYLE SM BARIE PS DEMARIA E REINES HD SNYDMAN D SCHWAITZBERG S NASRAWAY S GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D BLEICHNER G DAHN M HALL J WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J SHELLY MP NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON G SENEFF M CONRY K ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D LAURELL MH JACOBS S ASH S OPAL SM SLOTMAN GJ IBERTI TJ SADOFF JC STILES DM THOMPSON B PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDMAN H WITTES J THOMPSON BW LABRECQUE JF CATALANO MA CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Wa. Knaus et al., USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS, Critical care medicine, 24(1), 1996, pp. 46-56
THE ECONOMICS AND COST-EFFECTIVENESS OF CRITICAL CARE MEDICINE
Authors: CHALFIN DB COHEN IL LAMBRINOS J
Citation: Db. Chalfin et al., THE ECONOMICS AND COST-EFFECTIVENESS OF CRITICAL CARE MEDICINE, Intensive care medicine, 21(11), 1995, pp. 952-961
PREOPERATIVE EVALUATION AND POSTOPERATIVE CARE OF THE ELDERLY PATIENTUNDERGOING MAJOR SURGERY
Authors: CHALFIN DB NASRAWAY SA
Citation: Db. Chalfin et Sa. Nasraway, PREOPERATIVE EVALUATION AND POSTOPERATIVE CARE OF THE ELDERLY PATIENTUNDERGOING MAJOR SURGERY, Clinics in geriatric medicine, 10(1), 1994, pp. 51-70
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC ASTIZ M CARPATI C BONE RC FREIDMAN B MURE AJ BRATHWAITE C SHAPIRO E MELHORN L TAYLOR R KEEGAN M OBRIEN J SCHEIN R PENA M WASSERLOUF M OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAM N MERRICK DK BERGQUIST W MATZEL KE HUEBLER M FOULKE GE ALBERTSON TE WALBY WF ALLEN RP BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMPSON BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C STORER S GERVICH DH FOSHE D BRASE R BAGDAHN A COONEY R SMITH JS MARTIN LF VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN HG DURKIN MR DUBIN PK STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUWEN PAM BOERMEESTER MA SCHNEIDER AJ BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N SILVERSTEIN J ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL JA KRUGER R DRUMMOND A LANGE P SEIFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY SF COYLE SM BARIE PS DEMARIA E SNYDMAN DR SCHWAITZBERG SD NASRAWAY SA GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D CAMPBELL D BLEICHNER G DAHN MS LANGE MPA HALL J POHLMAN A WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON GL SENEFF MG CONRY KM ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D PORTER JC LAURELL MH JACOBS S ASH S STILES DM PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDEMAN H WITTES J CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(23), 1994, pp. 1836-1843
CONSENSUS STATEMENT ON THE TRIAGE OF CRITICALLY ILL PATIENTS
Authors: KOHLENBERGER C SPRUNG CL DANIS M ARMSTRONG C BAILY MA CHALFIN DB DAGI TF DAVILA F DEVITA M ENGELHARDT HT GRENVIK A HOFMANN PB HOYT JW JAMETON A KOFKE WA LYNN J MARSHALL MF MCCARTNEY JJ NELSON RM NINOS N RAPHAELY RC REARDON F RIE MA ROSENBAUM SH SILVERMAN H SOTTILE FD SPANIER A STEINBERG A TENDLER MD TERES D TRUOG RD WALLACE TE WLODY G YEH TS
Citation: C. Kohlenberger et al., CONSENSUS STATEMENT ON THE TRIAGE OF CRITICALLY ILL PATIENTS, JAMA, the journal of the American Medical Association, 271(15), 1994, pp. 1200-1203
JOINT POSITION STATEMENT - ESSENTIAL PROVISIONS FOR CRITICAL CARE IN HEALTH SYSTEM REFORM
Authors: RAINEY TG RAPHAELY RC CHALFIN DB PARKS LK FITZPATRICK MA CONNOR SJ JOHANSON WL KALOWES PG
Citation: Tg. Rainey et al., JOINT POSITION STATEMENT - ESSENTIAL PROVISIONS FOR CRITICAL CARE IN HEALTH SYSTEM REFORM, Critical care medicine, 22(12), 1994, pp. 2017-2019
THE ECONOMIC-IMPACT AND COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODY THERAPY FOR SEPSIS
Authors: CHALFIN DB FEIN AM
Citation: Db. Chalfin et Am. Fein, THE ECONOMIC-IMPACT AND COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODY THERAPY FOR SEPSIS, Clinical infectious diseases, 17, 1993, pp. 190000520-190000524
OUTCOME ASSESSMENT IN ELDERLY PATIENTS WITH CRITICAL ILLNESS AND RESPIRATORY-FAILURE
Authors: CHALFIN DB
Citation: Db. Chalfin, OUTCOME ASSESSMENT IN ELDERLY PATIENTS WITH CRITICAL ILLNESS AND RESPIRATORY-FAILURE, Clinics in chest medicine, 14(3), 1993, pp. 583-589
Risultati: 1-12 |